BASF, Amarin Pharma and other defendants were hit with an antitrust class action Wednesday in New Jersey District Court. The suit accuses the defendants of blocking the supply of a key ingredient in order to delay generic competition to its branded Vascepa treatment. The complaint was field by Carella Byrne Cecchi Olstein Brody & Agnello; Glancy Prongay & Murray; Kessler Topaz Meltzer & Check; and other law firms. Counsel have not yet appeared for the defendants. The case is 2:21-cv-12061, Uniformed Fire Officers Association Family Protection Plan Local 854 et al v. Amarin Pharma, Inc. et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.

Read the complaint here: